semaglutide canada price Pharmacy Expert Projects $100/Month Generic in Should Wegovy, the $400-a-month obesity

The prevalence of metabolic dysfunction in autoimmune disease may relate to chronic inflammation, corticosteroid therapy, reduced physical activity due to disease burden, or shared genetic susceptibilities

Nationally, 28% of Canadians living with overweight or obesity said they would consider a GLP-1 at a hypothetical cost of $100 per month, but only 5% would at $400 per month, according to an Angus Reid survey commissioned by Felix in December 2025

This medication targets very specific genetic forms of obesity rather than common obesity

Understanding Semaglutide Semaglutide is an FDA-approved GLP-1 receptor agonist widely used for managing weight in adults with obesity or those overweight with related health conditions

Food and Drug Administration (2024)